Pharmarise Holdings Corporation (TYO:2796)
Japan flag Japan · Delayed Price · Currency is JPY
509.00
+1.00 (0.20%)
Oct 2, 2026, 3:30 PM JST

Pharmarise Holdings Financials Overview

Millions JPY. Fiscal year is Jun - May.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 May '26 May '25 May '24 May '23 May '22
Revenue
70,00169,51263,50854,46652,03051,608
Revenue Growth
7.64%9.45%16.60%4.68%0.82%-1.37%
Gross Profit
9,4609,4598,9668,4498,1348,117
Operating Income
8591,0072959161,4391,521
Net Income
96114-367-351333447
Earnings Per Share
8.099.62-32.42-33.3526.8636.22
EPS Growth
-----25.83%4.70%

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 May '26 May '25 May '24 May '23 May '22
Medical Mall Management
500505511506505503
Other
1,1969861,064834779764
Dispensing Pharmacy
59,65459,33152,62544,17842,32742,038
Storage and Management of Medical Documents
628647609664646699
Drug/Convenience Store
8,0238,0428,6968,2837,7717,602
Total
70,00169,51163,50554,46552,02851,606

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 May '26 May '25 May '24 May '23 May '22
Cash & Investments
2,9416,0124,9117,1504,7423,991
Total Debt
13,83015,15214,27912,7499,1389,912
Net Cash (Debt)
-10,889-9,140-9,368-5,599-4,396-5,921
Net Cash Growth
------
Net Cash Per Share
-910.80-766.78-827.45-532.02-352.52-477.64

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 May '26 May '25 May '24 May '23 May '22
Operating Cash Flow
-3,2781,3112,7142,520713
Capital Expenditures
--696-637-472-380-379
Free Cash Flow
-2,5826742,2422,140334
Free Cash Flow Growth
-283.09%-69.94%4.77%540.72%-76.76%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 May '26 May '25 May '24 May '23 May '22
Gross Margin
13.51%13.61%14.12%15.51%15.63%15.73%
Operating Margin
1.23%1.45%0.46%1.68%2.77%2.95%
Pretax Margin
0.92%1.01%0.02%0.26%2.02%2.56%
Profit Margin
0.14%0.16%-0.58%-0.64%0.64%0.87%
FCF Margin
-3.71%1.06%4.12%4.11%0.65%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 May '26 May '25 May '24 May '23 May '22
Dividend Per Share
14.00014.00014.00014.00014.00014.000
Dividend Per Share Growth
0%0%0%0%0%0%
Dividend Yield
2.75%2.77%2.96%2.29%2.50%2.15%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 May '26 May '25 May '24 May '23 May '22
PE Ratio
62.9551.06--17.2915.23
Forward PE
-7.307.307.307.307.30
P/FCF Ratio
2.272.258.183.242.6920.39
PS Ratio
0.080.080.090.130.110.13